Passion Health Primary Care Blog foundayo vs Trulicity & 11 GLP-1 Drugs: Benefits, foundayo vs Trulicity & 11 GLP-1 Drugs: Benefits,& How to Choose Safely

foundayo vs Trulicity & 11 GLP-1 Drugs: Benefits, foundayo vs Trulicity & 11 GLP-1 Drugs: Benefits,& How to Choose Safely

Need care for this?

A Passion Health clinician can see you in person or online.

In person

Request an in-person visit at any Passion Health location to review your cholesterol numbers and heart risk.

Choose your clinic and clinician across North Texas

Book an appointment in person at Passion Health clinics

Online

Answer a few questions online to find the right next step, whether that is a visit, lab work, or a referral. For non-emergency questions, you can get care online through Passion Health Online Care.

Adults 18 and older in Texas · Texas-licensed clinicians

Get the right care in a few steps

Blood work

Your clinician can order a lipid panel and any other labs recommended for you during your visit.

Essential Blood Work · $59

Get Passion Health Blood Work

Frequently Asked Questions

Key takeaways

  • GLP-1 medicines mimic a gut hormone that helps regulate blood sugar and appetite.
  • Options include weekly injections such as Ozempic and Wegovy, daily pills, and newer medicines such as Foundayo.
  • The best choice depends on your goals, whether you have diabetes or are focused on weight, and your health history.
  • Nausea, vomiting, and diarrhea are the most common side effects, especially when starting.
  • All of these are prescription medicines, so a clinician should review your health before you start.

Are GLP-1 drugs the same as insulin?

No. GLP-1 medicines work differently from insulin. They mimic a gut hormone that helps regulate blood sugar and appetite, while insulin is a hormone that moves sugar from the blood into cells.

Can I switch from one GLP-1 medication to another?

Some people can switch, but the right move depends on the medication, your dose, and your health history. Your prescriber can guide the transition.

What side effects are most common with GLP-1 drugs?

Nausea, vomiting, diarrhea, and constipation are the most common side effects, especially when starting or raising the dose. Contact your clinician if symptoms are severe or do not improve.

Do GLP-1 drugs require a prescription?

Yes. Every medication in this guide is a prescription medicine, so a clinician needs to review your health history before you start.

11 GLP-1 Drugs Explained: Foundayo, Trulicity, and More

Reviewed by a Passion Health physician

If you’ve been hearing about Foundayo, Ozempic, Trulicity, or GLP-1 drugs for weight loss and diabetes, you’re not alone. These medications are transforming how doctors treat type 2 diabetes and obesity—but with so many options available, choosing the right one can feel confusing.

Some help control blood sugar. Others are approved specifically for weight loss. And a few do both.

In this guide, you’ll learn:

  • What GLP-1 drugs actually do

  • A breakdown of 11 popular medications

  • Key differences between Ozempic, Trulicity, and others

  • How to choose the option that best fits your health and goals

If you’re considering these medications, this guide can help you prepare for a conversation with your doctor.

Not sure which GLP-1 medication is right for you? Don’t guess.

What Are GLP-1 Drugs and How Do They Work?

GLP-1 receptor agonists are medications that mimic a natural hormone in your body called glucagon-like peptide-1.

They work in three powerful ways:

  • Increase insulin release (lowers blood sugar)

  • Reduce glucose production in the liver

  • Slow digestion and increased fullness

This combination helps improve diabetes control and often leads to weight loss as a side benefit. 

Ozempic (Semaglutide Injection)

FDA-approved for: Type 2 diabetes in adults
Dosing: Once-weekly injection, any time of day, with or without food
Device: Multi-dose pre-filled pen

Ozempic does more than lower blood sugar. Clinical trials show it reduces major cardiovascular events. If you have Type 2 diabetes and heart disease, Ozempic lowers your risk of heart attack, stroke, and cardiovascular death. The same benefit applies if you have chronic kidney disease. Ozempic slows kidney disease progression and reduces kidney failure risk.

Weight loss effect: Ozempic is not approved for weight loss. However, clinical trial participants lost 8 to 10 pounds on average after 30 weeks. Higher-dose semaglutide products (Wegovy) target weight loss specifically.

Key trial evidence: The SUSTAIN series of trials enrolled over 8,000 patients. Clinical studies showed meaningful reductions in HbA1c, a measure of average blood sugar over time. In studies, cardiovascular outcomes were better than with placebo.

Rybelsus (Oral Semaglutide)

FDA-approved for: Type 2 diabetes in adults; also has data on fewer major heart events in high-risk adults.Dosing: Once daily, first thing in the morning, with no more than 4 ounces of water. Wait 30 minutes before eating or drinking anything else.Device: Oral tablet (R1 formulation; R2 formulation now sold as Ozempic branded pill)

Rybelsus solves the injection problem. You get semaglutide in a daily pill. Absorption requires strict timing. Take it immediately upon waking. Use only plain water. Wait half an hour. This ensures the medication reaches your bloodstream effectively.

Switching between Ozempic and Rybelsus: Possible, but not if your Ozempic dose exceeds 1 mg. Your prescriber can guide the transition.

Clinical data: The PIONEER trial program showed meaningful HbA1c reductions. The highest dose (14 mg) produced these results consistently.

Wegovy Injection (Semaglutide 2.4 mg)

FDA-approved for: Weight loss in adults and adolescents (ages 12+); also reduces MACE risk in adults with heart disease and larger body size; treats MASH with moderate-to-advanced liver fibrosis.
Dosing: Once-weekly injection, single-dose pen
Device: Single-dose pre-filled pen

Wegovy is not for diabetes. You do not need a diabetes diagnosis. The approval covers obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition like high blood pressure, high cholesterol, or Type 2 diabetes.

Weight loss results from clinical trials:

  • Adults in trials lost a meaningful share of their starting body weight on average
  • Adolescents in trials also lost a meaningful share of their starting body weight
  • Wegovy HD (higher dose) produced greater average weight loss in trials

Cardiovascular benefit: The SELECT trial showed fewer major heart events compared with placebo. This trial included over 17,000 adults.

MASH approval: Wegovy has been approved for metabolic dysfunction-associated steatohepatitis with moderate-to-advanced fibrosis but without cirrhosis.

Wegovy Pill (Oral Semaglutide for Weight Loss)

FDA-approved for: Weight loss in adults only (not adolescents)
Dosing: Once daily, same timing as Rybelsus (morning, empty stomach, 4 oz water, wait 30 minutes)
Device: Oral tablet

The Wegovy pill delivers semaglutide for weight loss without injections. Adults in clinical trials lost a meaningful share of their starting body weight on average. Those who completed the full trial lost more weight on average.

Important limitation: Unlike the Wegovy injection, the pill version is not approved for MASH treatment. It does carry the MACE risk reduction indication for adults with larger body size and heart disease.

Trulicity (Dulaglutide)

FDA-approved for: Type 2 diabetes in adults and children (ages 10+)
Dosing: Once-weekly injection, same day each week, any time of day
Device: Single-use pre-filled pen

Trulicity reduces MACE risk in adults with heart disease or heart disease risk factors. It also provides kidney-related benefits. However, Trulicity is not approved for weight loss.

Weight loss as a side effect: One study found that adults on the highest Trulicity dose (4.5 mg) lost up to 10 pounds over 9 months.

Pediatric use: Trulicity is one of the few GLP-1 drugs approved for children aged 10 and older with Type 2 diabetes.

Victoza (Liraglutide)

FDA-approved for: Type 2 diabetes in adults and children (ages 10+)
Dosing: Once-daily injection, any time of day
Device: Multi-dose pre-filled pen

Victoza reduces MACE risk in patients with heart disease. Evidence also suggests it slows kidney disease progression. Weight loss averages around 5 pounds in clinical trials.

Cost advantage: Generic liraglutide is available. Victoza has a lower-cost generic alternative. If insurance denies coverage or copays remain high, generic Victoza offers an affordable entry point into GLP-1 treatment.

Note on higher dosing: Saxenda (see below) contains the same active ingredient at a higher dose for weight loss.

Saxenda (Liraglutide 3.0 mg)

FDA-approved for: Weight loss in adults and adolescents (ages 12+)
Dosing: Once-daily injection
Device: Multi-dose pre-filled pen

Saxenda uses the same liraglutide molecule as Victoza, but at a higher strength. Approval criteria match Wegovy: BMI ≥30 or BMI ≥27 with a weight-related condition.

Weight loss results from clinical trials:

  • Adults in trials lost a more modest share of their starting body weight on average
  • Adolescents in trials lost a smaller share of their body weight on average

Head-to-head comparison with Wegovy: A direct study showed Wegovy produced greater weight loss than Saxenda. Wegovy also requires weekly injections instead of daily. Your prescriber will help you weigh convenience against cost.

Generic availability: Generic liraglutide for weight loss (the Saxenda strength) is now available. This makes Saxenda the first GLP-1 weight loss medication with a generic alternative.

Byetta (Exenatide)

FDA-approved for: Type 2 diabetes in adults
Dosing: Twice daily, within 60 minutes before morning and evening meals
Device: Multi-dose pre-filled pen

Byetta was the first GLP-1 drug ever approved. It remains useful for patients who experience blood sugar spikes after meals. The twice-daily schedule aligns with meal times.

Limitations: Byetta has less cardiovascular research than newer GLP-1 drugs. It does cause weight loss as a side effect, but not at the level of semaglutide or tirzepatide.

Generic availability: Generic exenatide is available at a lower cost. However, the twice-daily dosing makes Byetta less convenient than once-weekly options.

Mounjaro (Tirzepatide)

FDA-approved for: Type 2 diabetes in adults and children (ages 10+)
Dosing: Once-weekly injection
Device: Single-dose pen, multi-dose pen (KwikPen), or vial

Mounjaro is not a pure GLP-1 agonist. It belongs to a new class: dual GLP-1/GIP agonists. It activates two gut hormones at once. This dual action produces superior blood sugar control and weight loss compared to semaglutide alone.

Head-to-head trial against Ozempic (SURPASS-2):
After 40 weeks, Mounjaro patients achieved better HbA1c reduction. They also lost significantly more weight.

Pending indications: Mounjaro is currently under regulatory review for MACE risk reduction. Tirzepatide continues to be studied for additional uses, including heart failure and sleep apnea.

Zepbound (Tirzepatide for Weight Loss)

FDA-approved for: Weight loss in adults; also treats moderate-to-severe obstructive sleep apnea (OSA) in adults with larger body size.e
Dosing: Once-weekly injection
Device: Single-dose pen, multi-dose pen (KwikPen), or vial

Zepbound contains the same tirzepatide molecule as Mounjaro. The approval covers the same BMI criteria as Wegovy and Saxenda. However, Zepbound is not yet approved for adolescents.

Weight loss results from clinical trials (SURMOUNT-1):

  • At 72 weeks, participants on the highest dose lost substantially more weight than those on placebo
  • The placebo group lost much less weight

Head-to-head with Wegovy: A recent study showed greater weight loss with Zepbound compared to Wegovy. Zepbound has not been compared directly to Wegovy HD in published trials.

OSA approval: Zepbound became the first GLP-1 drug approved for obstructive sleep apnea.

Foundayo (Orforglipron): Emerging Oral GLP-1

FDA-approved for: Weight loss in adults
Dosing: Once daily by mouth, with or without food
Device: Oral tablet

Foundayo represents a new chemical class. Unlike other GLP-1 pills (Rybelsus, Wegovy pill), Foundayo is a small-molecule drug. It does not require strict fasting or water restrictions. You can take it with food at any time of day.

Weight loss results from phase 3 trials:

  • The highest dose produced meaningful body weight loss over 72 weeks
  • No increased risk of gallbladder disease compared to placebo

Choosing between GLP-1 drugs can feel overwhelming—but you don’t have to figure it out alone.

A medical provider can help you compare effectiveness, side effects, and cost based on your personal health profile.

How to Choose the Right GLP-1 Medication

Selecting the best option depends on several clinical factors:

Treatment Goal

  • Diabetes control → Ozempic, Trulicity, Mounjaro

  • Weight loss → Wegovy, Zepbound, Saxenda

Dosing Preference

  • Weekly injections → More convenient

  • Daily injections or pills → More flexibility

Health Conditions

  • Heart disease → Consider medications with cardiovascular benefits shown in studies
  • Kidney disease → Consider options with kidney-related research, such as Ozempic

Cost and Access

  • Generic options like Victoza and Byetta may reduce expenses

When to See a Doctor 

You should speak with a healthcare provider if you experience:

  • Uncontrolled blood sugar levels

  • Difficulty losing weight despite lifestyle changes

  • Severe side effects like persistent nausea or vomiting

  • Signs of complications (abdominal pain, dehydration, fatigue)

  • A history of thyroid issues, pancreatitis, or digestive disorders

Early medical guidance can help you choose the right medication, dosage, and monitoring plan.

How Passion Health Helps You Choose the Right GLP-1 Treatment

At Passion Health Primary Care, our experienced providers help you navigate GLP-1 medications with a personalized, evidence-based approach. Whether you’re managing diabetes or looking for sustainable weight loss, we focus on:

  • Customized treatment plans

  • Ongoing monitoring and support

  • Safe medication selection based on your health history

Final Takeaway

GLP-1 medications offer powerful benefits for managing type 2 diabetes and obesity, but the right choice depends on your individual health profile, goals, and tolerance.

  • For stronger weight loss → consider newer options like tirzepatide-based treatments.

  • For diabetes with heart protection → semaglutide or dulaglutide may be preferred.

  • For convenience → weekly injections or flexible oral options

 

Related Post